NZ334546A - Erythropoietin receptor agonist and use in the treatment of hematopoietic disorders - Google Patents
Erythropoietin receptor agonist and use in the treatment of hematopoietic disordersInfo
- Publication number
- NZ334546A NZ334546A NZ334546A NZ33454697A NZ334546A NZ 334546 A NZ334546 A NZ 334546A NZ 334546 A NZ334546 A NZ 334546A NZ 33454697 A NZ33454697 A NZ 33454697A NZ 334546 A NZ334546 A NZ 334546A
- Authority
- NZ
- New Zealand
- Prior art keywords
- receptor agonist
- treatment
- erythropoietin receptor
- hematopoietic disorders
- hematopoietic
- Prior art date
Links
- 208000018706 hematopoietic system disease Diseases 0.000 title abstract 2
- 229940087983 Erythropoietin receptor agonist Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000925 erythroid effect Effects 0.000 abstract 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
- 102000044890 human EPO Human genes 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3404496P | 1996-10-25 | 1996-10-25 | |
| PCT/US1997/018703 WO1998018926A1 (en) | 1996-10-25 | 1997-10-23 | Circularly permuted erythropoietin receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ334546A true NZ334546A (en) | 2000-12-22 |
Family
ID=21873960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ334546A NZ334546A (en) | 1996-10-25 | 1997-10-23 | Erythropoietin receptor agonist and use in the treatment of hematopoietic disorders |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060172932A1 (enExample) |
| EP (1) | EP0939816A1 (enExample) |
| JP (1) | JP2001503266A (enExample) |
| KR (1) | KR20000052807A (enExample) |
| CN (1) | CN1234073A (enExample) |
| AU (1) | AU721196B2 (enExample) |
| BR (1) | BR9712675A (enExample) |
| CA (1) | CA2268001A1 (enExample) |
| CZ (1) | CZ130199A3 (enExample) |
| NO (1) | NO991906L (enExample) |
| NZ (1) | NZ334546A (enExample) |
| PL (1) | PL189756B1 (enExample) |
| WO (1) | WO1998018926A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7309687B1 (en) | 1999-04-13 | 2007-12-18 | The Kenneth S. Warren Institute, Inc. | Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin |
| US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
| US7604960B2 (en) | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
| US8236561B2 (en) | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
| US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
| US7297680B2 (en) | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
| US7527961B2 (en) | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
| US7192759B1 (en) | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
| US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| PA8536201A1 (es) | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
| US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| ATE384785T1 (de) | 2001-12-07 | 2008-02-15 | Crucell Holland Bv | Herstellung von viren, virusisolaten, und impfstoffen |
| NZ542585A (en) | 2003-05-09 | 2007-11-30 | Crucell Holland Bv | Cultures of PER.C6-immortalized cells and processes for culturing the same to increase product yields therefrom |
| CA2595676A1 (en) * | 2005-01-25 | 2006-08-03 | Apollo Life Sciences Limited | Molecules and chimeric molecules thereof |
| US8128933B2 (en) | 2005-11-23 | 2012-03-06 | Acceleron Pharma, Inc. | Method of promoting bone growth by an anti-activin B antibody |
| BRPI0618947B1 (pt) | 2005-11-23 | 2022-07-19 | Acceleron Pharma Inc | Polipeptídeo actriia que se liga à ativina, polinucleotídeo isolado, polinucleotídeo recombinante, métodopara preparar um polipeptídeo actriia que se liga à ativina, preparação farmacêutica e uso de uma proteína de fusão actriia-fc para promover o crescimento ósseo e inibir a ressorção óssea |
| CA2621705A1 (en) * | 2005-11-24 | 2007-05-31 | Laboratoires Serono S.A. | Erythropoietin polypeptides and uses thereof |
| US8895016B2 (en) | 2006-12-18 | 2014-11-25 | Acceleron Pharma, Inc. | Antagonists of activin-actriia and uses for increasing red blood cell levels |
| TWI584815B (zh) | 2007-02-01 | 2017-06-01 | 艾瑟勒朗法瑪公司 | 活化素-ＡｃｔＲＩＩａ拮抗劑及其治療或預防乳癌之用途 |
| TW201627320A (zh) | 2007-02-02 | 2016-08-01 | 艾瑟勒朗法瑪公司 | 衍生自ＡｃｔＲＩＩＢ的變體與其用途 |
| MX2009008510A (es) | 2007-02-09 | 2010-01-15 | Acceleron Pharma Inc | Antagonistas de activina-actriia y usos para promover el crecimiento de huesos en pacientes con cancer. |
| CA2699936A1 (en) | 2007-09-18 | 2009-03-26 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion |
| DK3750552T5 (da) | 2008-08-14 | 2024-08-26 | Acceleron Pharma Inc | Gdf-fælder |
| US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
| MX355042B (es) | 2009-06-08 | 2018-04-02 | Acceleon Pharma Inc | Metodos para aumentar adipositos termogenicos. |
| CN107267520A (zh) | 2009-06-12 | 2017-10-20 | 阿塞勒隆制药公司 | 截短的actriib‑fc融合蛋白 |
| ES2658292T3 (es) | 2009-11-17 | 2018-03-09 | Acceleron Pharma, Inc. | Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular |
| CA2817008A1 (en) | 2010-11-08 | 2012-05-18 | Acceleron Pharma Inc. | Actriia binding agents and uses thereof |
| US9156897B2 (en) | 2012-06-08 | 2015-10-13 | Alkermes, Inc. | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide |
| RU2678117C2 (ru) | 2012-11-02 | 2019-01-23 | Селджин Корпорейшн | Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений |
| CN114699529A (zh) | 2014-06-13 | 2022-07-05 | 阿塞勒隆制药公司 | 用于治疗溃疡的方法和组合物 |
| MA41052A (fr) | 2014-10-09 | 2017-08-15 | Celgene Corp | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii |
| EP3227675B1 (en) | 2014-12-03 | 2023-03-15 | Celgene Corporation | Activin-actrii antagonists and uses for treating myelodysplastic syndrome |
| CN110144010B9 (zh) * | 2018-02-14 | 2021-01-05 | 上海洛启生物医药技术有限公司 | 阻断型pd-l1驼源单域抗体及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| JPH05502463A (ja) * | 1990-09-28 | 1993-04-28 | オーソ・フアーマシユーチカル・コーポレーシヨン | ハイブリツド成長因子 |
| US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
| US5635599A (en) * | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
-
1997
- 1997-10-23 CA CA002268001A patent/CA2268001A1/en not_active Abandoned
- 1997-10-23 WO PCT/US1997/018703 patent/WO1998018926A1/en not_active Ceased
- 1997-10-23 CZ CZ991301A patent/CZ130199A3/cs unknown
- 1997-10-23 PL PL97332960A patent/PL189756B1/pl not_active IP Right Cessation
- 1997-10-23 KR KR1019990703627A patent/KR20000052807A/ko not_active Ceased
- 1997-10-23 EP EP97913680A patent/EP0939816A1/en not_active Withdrawn
- 1997-10-23 AU AU50810/98A patent/AU721196B2/en not_active Ceased
- 1997-10-23 BR BR9712675-6A patent/BR9712675A/pt not_active Application Discontinuation
- 1997-10-23 NZ NZ334546A patent/NZ334546A/xx unknown
- 1997-10-23 JP JP52052898A patent/JP2001503266A/ja not_active Abandoned
- 1997-10-23 CN CN97198973A patent/CN1234073A/zh active Pending
-
1999
- 1999-04-21 NO NO991906A patent/NO991906L/no not_active Application Discontinuation
-
2004
- 2004-10-25 US US10/972,962 patent/US20060172932A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998018926A1 (en) | 1998-05-07 |
| CN1234073A (zh) | 1999-11-03 |
| CA2268001A1 (en) | 1998-05-07 |
| AU5081098A (en) | 1998-05-22 |
| PL332960A1 (en) | 1999-10-25 |
| AU721196B2 (en) | 2000-06-29 |
| CZ130199A3 (cs) | 1999-07-14 |
| BR9712675A (pt) | 1999-10-19 |
| PL189756B1 (pl) | 2005-09-30 |
| KR20000052807A (ko) | 2000-08-25 |
| JP2001503266A (ja) | 2001-03-13 |
| NO991906D0 (no) | 1999-04-21 |
| US20060172932A1 (en) | 2006-08-03 |
| EP0939816A1 (en) | 1999-09-08 |
| NO991906L (no) | 1999-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1157098T3 (da) | Apparat og fremgangsmåde til at fremstille og anvende höj-densitet celler og deres produkter | |
| EP0326034A3 (en) | Combination for the treatment of nervous cells and fibers illnesses and disorders | |
| ZA907803B (en) | Electrochemical cells and preparing carbon fibrils | |
| EP0737750A3 (en) | Expression of exogenous polynucleotide sequences in vertebrates | |
| PT793714E (pt) | Utilizacao do factor de celulas estaminais e do receptor de interleucina 6 soluvel para a expansao ex vivo de celulas hematopoieticas multipotentes | |
| NO880863D0 (no) | Humant erytropoietingen: hoey ekspresjon i stabilt transfekterte pattedyrceller. | |
| ATE40365T1 (de) | 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung. | |
| DE68929422D1 (de) | Nukleophile polysubstituierte Arylacridiniumester, deren Konjugate, sowie deren Herstellung und Verwendungen | |
| PT2143420E (pt) | Formulação contendo um ou mais mutantes da alfa-galactosidade a lisossomal para o tratamento da doença de fabry | |
| GB8806737D0 (en) | Therapeutic composition & method | |
| AU4039589A (en) | Apparatus and method for transmitting prosthetic information to the brain | |
| DE69830143D1 (en) | Phosphodiesterase 8 | |
| DE3864638D1 (de) | Schaftfraeser mit runder stirn und schneideinsaetzen. | |
| EP0276543A3 (en) | Use of buspirone for the improvement of short term memory | |
| DE69420251D1 (de) | Löslicher Interferon-Rezeptor, seine Herstellung und Anwendung | |
| EP1014880A4 (en) | INCREASE OR REPAIR OF SKIN TISSUE, SUBCUTANEOUS OR VOICE ROPE ABNORMALITIES | |
| EP0095804A3 (en) | Process and fermenter for cultivating tissue cells | |
| DK6789A (da) | Fremgangsmaade og apparat til at undertrykke no dannelse i regenerative braendere. | |
| DE68927104D1 (de) | Gentherapie unter verwendung von genschmelzen für genetische und erworbene störungen | |
| AU593264B2 (en) | Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor | |
| AU7577091A (en) | Process for the artificial stimulation of cells and cyte culture device | |
| EP0452894A3 (en) | Human cells for the high expression of genes inserted in episomal recombinant dna, their preparation and their use | |
| ZA873211B (en) | Animal cell transformant,method for obtaining the transformant and method for producing desired foreign gene product by using the transformant | |
| AU4128385A (en) | Method for sterilizing artificial organs and apparatus used therefor | |
| DE69025308D1 (de) | Enzyme die teilnehmen an c-endamidierung, herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |